CBMG - Cellular Biomedicine Group Stock Trading

Cellular Biomedicine Group Inc.(NASDAQ: CBMG) stock trading, description, contact, officers and directors.

About Cellular Biomedicine Group Inc.

Cellular Biomedicine Group, Inc. CBMG is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, i haMPC human adipose derived mesenchymal progenitor cells for treatment of joint disease, ii huMPC human umbilical cord derived mesenchymal progenitor cells , iii TC DC tumor cell specific dendritic cells for treatment of a broad range of cancers and iv MNP human embryo derived motor neuron precursor cells and NP human embryo derived neuronal precursor cells for treatment of central nervous system diseases.

Stock Information

Cellular Biomedicine Group Inc. Company Name:

CBMG Stock Symbol:

NASDAQ Market:

CBMG CBMG Quote CBMG Short CBMG News CBMG Articles CBMG Message Board

Get CBMG Alerts

News, Short Squeeze, Breakout and More Instantly...

CBMG - STOCKHOLDER ALERT: Monteverde & Associates Continues its Investigation into the Following Merger

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...
CBMG - STOCKHOLDER ALERT: Monteverde & Associates Reminds Shareholders of its Continuing Investigation Regarding the Merger

NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc . ( AKCA ) relating t...
CBMG - Monteverde & Associates Reminds Shareholders of its Ongoing Investigation Regarding the Merger

NEW YORK, NY / ACCESSWIRE / September 15, 2020 / Juan Monteverde , founder, and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Pfenex Inc. (NYSE American: PFNX ) relating to it...